Therapeutic compositions
US7250401B2 · kind B2 · utility
4Cited by
1References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 2004 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Sep 7, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for the preparation of compounds of the formula (R1)(R2)NC(═X)S(O)nR3 or (R1)(R2)NC(═X)OS(O)nR3, wherein R1, R2 and R3, X and n have any of the meanings defined in the specification. A method is also provided for the detection and quantitation of compounds of the formula (R1)(R2)NC(═X)OS(O)nR3. A method to link a therapeutic agent to a compound that is conjugated to glutathione is also provided for the purpose of improving the therapeutic properties of the therapeutic agent. Novel compounds, intermediates, pharmaceutical compositions and methods of use are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.